Compare NPO & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPO | TFX |
|---|---|---|
| Founded | 2002 | 1943 |
| Country | United States | United States |
| Employees | 4000 | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.8B |
| IPO Year | 2002 | 1994 |
| Metric | NPO | TFX |
|---|---|---|
| Price | $299.79 | $124.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $278.33 | $138.75 |
| AVG Volume (30 Days) | 127.2K | ★ 579.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | 0.46% | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.55 | 2.08 |
| Revenue | $1,532,000,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $12.31 | $15.97 |
| Revenue Next Year | $6.39 | $5.15 |
| P/E Ratio | $116.15 | ★ $60.00 |
| Revenue Growth | ★ 16.98 | N/A |
| 52 Week Low | $202.00 | $100.18 |
| 52 Week High | $390.42 | $145.00 |
| Indicator | NPO | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 35.00 |
| Support Level | $293.51 | $119.69 |
| Resistance Level | $303.49 | $127.49 |
| Average True Range (ATR) | 9.07 | 3.74 |
| MACD | 1.38 | -1.26 |
| Stochastic Oscillator | 68.28 | 16.38 |
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.